Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 7,149 | 8,260 | 21,675 | 8,765 | 16,419 |
| Cost of Goods | 2,788 | 2,978 | 3,539 | 3,659 | 6,792 |
| Gross Profit | 4,361 | 5,282 | 18,136 | 5,106 | 9,627 |
| Operating Expenses | 20,795 | 20,041 | 18,280 | 19,626 | 20,323 |
| Operating Income | -15,646 | -13,781 | 395 | -13,861 | -9,904 |
| Interest Expense | 4,726 | 2,778 | 2,747 | 2,771 | 2,803 |
| Other Income | 4 | 8 | 18 | 102 | 71 |
| Pre-tax Income | -20,368 | -16,551 | -2,334 | -16,530 | -12,636 |
| Net Income Continuous | -20,368 | -16,551 | -2,334 | -16,530 | -12,636 |
| Net Income | $-20,368 | $-16,551 | $-2,334 | $-16,530 | $-12,636 |
| EPS Basic Total Ops | -0.61 | -0.49 | -0.07 | -0.49 | -0.46 |
| EPS Basic Continuous Ops | -0.60 | -0.49 | -0.07 | -0.49 | -0.47 |
| EPS Diluted Total Ops | -0.61 | -0.49 | -0.07 | -0.49 | -0.46 |
| EPS Diluted Continuous Ops | -0.60 | -0.49 | -0.07 | -0.49 | -0.47 |
| EBITDA(a) | $-13,711 | $-12,537 | $1,775 | $-12,390 | $-8,696 |